Wang B - Search Results

1

Detailed curriculum vitae of HER2-targeted therapy.

Zhang XN, Gao Y, Zhang XY, Guo NJ, Hou WQ, Wang SW, Zheng YC, Wang N, Liu HM, Wang B. Zhang XN, et al. Among authors: wang sw, wang n, wang b. Pharmacol Ther. 2023 May;245:108417. doi: 10.1016/j.pharmthera.2023.108417. Epub 2023 Apr 17. Pharmacol Ther. 2023. PMID: 37075933 Review.

2

Curriculum vitae of HDAC6 in solid tumors.

Zheng YC, Kang HQ, Wang B, Zhu YZ, Mamun MAA, Zhao LF, Nie HQ, Liu Y, Zhao LJ, Zhang XN, Gao MM, Jiang DD, Liu HM, Gao Y. Zheng YC, et al. Among authors: wang b. Int J Biol Macromol. 2023 Mar 1;230:123219. doi: 10.1016/j.ijbiomac.2023.123219. Epub 2023 Jan 13. Int J Biol Macromol. 2023. PMID: 36642357 Review.

3

New insights into the non-enzymatic function of HDAC6.

Zhu Y, Feng M, Wang B, Zheng Y, Jiang D, Zhao L, Mamun MAA, Kang H, Nie H, Zhang X, Guo N, Qin S, Wang N, Liu H, Gao Y. Zhu Y, et al. Among authors: wang n, wang b. Biomed Pharmacother. 2023 May;161:114438. doi: 10.1016/j.biopha.2023.114438. Epub 2023 Mar 9. Biomed Pharmacother. 2023. PMID: 37002569 Free article. Review.

4

Neddylation-dependent LSD1 destabilization inhibits the stemness and chemoresistance of gastric cancer.

Guo YJ, Pang JR, Zhang Y, Li ZR, Zi XL, Liu HM, Wang N, Zhao LJ, Gao Y, Wang B, Herdewijn P, Jin CY, Liu Y, Zheng YC. Guo YJ, et al. Among authors: wang n, wang b. Int J Biol Macromol. 2024 Jan;254(Pt 3):126801. doi: 10.1016/j.ijbiomac.2023.126801. Epub 2023 Sep 7. Int J Biol Macromol. 2024. PMID: 37689288

5

USP7 as an emerging therapeutic target: A key regulator of protein homeostasis.

Guo NJ, Wang B, Zhang Y, Kang HQ, Nie HQ, Feng MK, Zhang XY, Zhao LJ, Wang N, Liu HM, Zheng YC, Li W, Gao Y. Guo NJ, et al. Among authors: wang n, wang b. Int J Biol Macromol. 2024 Apr;263(Pt 1):130309. doi: 10.1016/j.ijbiomac.2024.130309. Epub 2024 Feb 19. Int J Biol Macromol. 2024. PMID: 38382779 Review.

6

KIAA1429 promotes tumorigenesis and gefitinib resistance in lung adenocarcinoma by activating the JNK/ MAPK pathway in an m⁶A-dependent manner.

Lin X, Ye R, Li Z, Zhang B, Huang Y, Du J, Wang B, Meng H, Xian H, Yang X, Zhang X, Zhong Y, Huang Z. Lin X, et al. Among authors: wang b. Drug Resist Updat. 2023 Jan;66:100908. doi: 10.1016/j.drup.2022.100908. Epub 2022 Dec 5. Drug Resist Updat. 2023. PMID: 36493511 Free article.

7

Retraction: Wang et al. Cardiovascular Disease and Exercise: From Molecular Mechanisms to Clinical Applications. J. Clin. Med. 2022, 11, 7511.

Wang B, Gan L, Deng Y, Zhu S, Li G, Nasser MI, Liu N, Zhu P. Wang B, et al. J Clin Med. 2023 Mar 9;12(6):2143. doi: 10.3390/jcm12062143. J Clin Med. 2023. PMID: 36983446 Free PMC article.

8

Characteristics of alpha-fetoprotein-positive gastric cancer revealed by analysis of cancer databases and transcriptome sequencing data.

Li Y, Lin Y, Zhao L, Yang C, Wang B, Gao Z, Ye Y, Wang S, Shen Z. Li Y, et al. Among authors: wang s, wang b. Transl Oncol. 2023 Oct;36:101737. doi: 10.1016/j.tranon.2023.101737. Epub 2023 Jul 19. Transl Oncol. 2023. PMID: 37478671 Free PMC article.

9

Cardiovascular Disease and Exercise: From Molecular Mechanisms to Clinical Applications.

Wang B, Gan L, Deng Y, Zhu S, Li G, Nasser MI, Liu N, Zhu P. Wang B, et al. J Clin Med. 2022 Dec 19;11(24):7511. doi: 10.3390/jcm11247511. J Clin Med. 2022. PMID: 36556132 Free PMC article. Retracted. Review.

10

SRC kinase-mediated signaling pathways and targeted therapies in breast cancer.

Luo J, Zou H, Guo Y, Tong T, Ye L, Zhu C, Deng L, Wang B, Pan Y, Li P. Luo J, et al. Among authors: wang b. Breast Cancer Res. 2022 Dec 29;24(1):99. doi: 10.1186/s13058-022-01596-y. Breast Cancer Res. 2022. PMID: 36581908 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44,080 results

Search Page